Skip to main content
. 2021 Apr 30;13:3601–3617. doi: 10.2147/CMAR.S300861

Table 6.

Correlation Between Methylation Detection Rate and the Clinicopathologic Features in Ade Stool Samples

Clinicopathological Parameters mSDC2 Rate (%) p value mTFPI2 Rate (%) p value Total Positive Detection Rate (%) p value
Sex
 Male (n=11) 63.6 (7/11) 1 63.6 (711) 0.245 72.7 (8/11) 0.509
 Female (n=5) 80.0 (4/5) 100.0 (5/5) 100.0 (5/5)
Age
 ≥ 60 (n=9) 77.8 (7/9) 0.596 66.7 (6/9) 0.585 66.7 (7/9) 1
 < 60 (n=7) 57.1 (4/7) 85.7 (6/7) 85.7 (6/7)
Location
 Left (n=13) 76.9 (10/13) 0.214 76.9 (10/13) 1 84.6 (11/13) 0.489
 Right (n=3) 33.3 (1/3) 66.7 (2/3) 66.7 (2/3)
Size
 ≥ 1 cm (n=8) 87.5 (7/8) 0.282 75.0(6/8) 1 87.5 (7/8) 1
 < 3 cm (n=8) 50.0 (4/8) 75.0 (6/8) 75.0 (6/8)
Villous component
 Yes (n=6) 100.0 (6/6) 0.093 83.3 (5/6) 1 100.0 (6/6) 0.25
 No (n=10) 50.0 (5/10) 70.0 (7/10) 70.0 (7/10)
Dysplasia
 Well differentiated (n=11) 72.7 (8/11) 1 72.7 (8/11) 1 81.8 (9/11) 1
 Poorly differentiated (n=5) 60.0 (3/5) 80.0 (4/5) 80.0 (4/5)

Notes: mSDC2 rate refers to detection rate of methylated SDC2; mTFPI2 rate refers to detection rate of methylated TFPI2; total positive rate refers to integrated detection rate of methylated SDC2 and TFPI2.